Pharmacokinetic and chemoprevention studies on tea in humans

Pharmacological Research

Volumn 64, Issue 2, 2011, Pages 105-112

  Chow, H H Sherry ^a   Hakim, Iman A ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Chemoprevention; Clinical trials; Pharmacokinetics; Tea

Indexed keywords

AMINO ACID; ASCORBIC ACID; CAFFEINE; CARBOHYDRATE DERIVATIVE; CARBOXYLIC ACID; CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; ERLOTINIB; FLAVANOL DERIVATIVE; FLAVONOID; GALLIC ACID; GLYCEROL; GREEN TEA EXTRACT; MINERAL; PLACEBO; POLYPHENON E; QUINIC ACID; THEAFLAVIN; THEANINE; THEARUBIGIN DERIVATIVE; THEOGALLIN; UNCLASSIFIED DRUG; VOLATILE FATTY ACID; XANTHINE DERIVATIVE;

AREA UNDER THE CURVE; CANCER PREVENTION; CANCER SURVIVAL; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; EPIGASTRIC DISCOMFORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSOMNIA; INTERVENTION STUDY; LEUKOPLAKIA; LUNG CANCER; MAXIMUM PLASMA CONCENTRATION; MOUTH CANCER; NERVOUSNESS; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; STRUCTURE ANALYSIS; TEA; TISSUE DISTRIBUTION; UTERINE CERVIX CARCINOMA IN SITU;

EID: 79959557659     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.05.007     Document Type: Article

References (44)

1. S.K. Katiyar, and H. Mukhtar Tea consumption and cancer World Rev Nutr Dietetics 79 1996 154 184 (Pubitemid 126119888)
2. C.S. Yang, and X. Wang Green tea and cancer prevention Nutr Cancer 62 7 2010 931 937
3. C.S. Yang, X. Wang, G. Lu, and S.C. Picinich Cancer prevention by tea: animal studies, molecular mechanisms and human relevance Nat Rev Cancer 9 6 2009 429 439
4. T.M. Rains, S. Agarwal, and K.C. Maki Antiobesity effects of green tea catechins: a mechanistic review J Nutr Biochem 22 1 2011 1 7
5. R. Cooper, D.J. Morre, and D.M. Morre Medicinal benefits of green tea. Part I. Review of noncancer health benefits J Altern Complement Med 11 3 2005 521 528 (Pubitemid 41001422)
6. R. Cooper, D.J. Morre, and D.M. Morre Medicinal benefits of green tea. Part II. Review of anticancer properties J Altern Complement Med 11 4 2005 639 652 (Pubitemid 41279080)
7. C.S. Yang, L. Chen, M.J. Lee, D. Balentine, M.C. Kuo, and S.P. Schantz Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers Cancer Epidemiol Biomarkers Prev 7 4 1998 351 354 (Pubitemid 28354149)
8. H.H. Chow, Y. Cai, D.S. Alberts, I. Hakim, R. Dorr, and F. Shahi Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E Cancer Epidemiol Biomarkers Prev 10 1 2001 53 58 (Pubitemid 32106044)
9. M.J. Lee, P. Maliakal, L. Chen, X. Meng, F.Y. Bondoc, and S. Prabhu Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability Cancer Epidemiol Biomarkers Prev 11 10 Pt 1 2002 1025 1032 (Pubitemid 35192653)
10. H.H. Chow, Y. Cai, I.A. Hakim, J.A. Crowell, F. Shahi, and C.A. Brooks Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals Clin Cancer Res 9 9 2003 3312 3319 (Pubitemid 37082725)
11. H.H. Chow, I.A. Hakim, D.R. Vining, J.A. Crowell, J. Ranger-Moore, and W.M. Chew Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals Clin Cancer Res 11 12 2005 4627 4633 (Pubitemid 40825654)
12. S.M. Henning, Y. Niu, N.H. Lee, G.D. Thames, R.R. Minutti, and H. Wang Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement Am J Clin Nutr 80 6 2004 1558 1564 (Pubitemid 41103853)
13. T.P. Mulder, C.J. van Platerink, P.J. Wijnand Schuyl, and J.M. van Amelsvoort Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry J Chromatogr B: Biomed Sci Appl 760 2 2001 271 279 (Pubitemid 32727250)
14. L. Chen, M.J. Lee, H. Li, and C.S. Yang Absorption, distribution, elimination of tea polyphenols in rats Drug Metab Disposition 25 9 1997 1045 1050 (Pubitemid 27396491)
15. J.D. Lambert, M.J. Lee, H. Lu, X. Meng, J.J. Hong, and D.N. Seril Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice J Nutr 133 12 2003 4172 4177 (Pubitemid 37505494)
16. Y. Cai, N.D. Anavy, and H.H. Chow Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats Drug Metab Disposition 30 11 2002 1246 1249 (Pubitemid 35265832)
17. Y.H. Kao, R.A. Hiipakka, and S. Liao Modulation of endocrine systems and food intake by green tea epigallocatechin gallate Endocrinology 141 3 2000 980 987 (Pubitemid 32260441)
18. C. Auger, W. Mullen, Y. Hara, and A. Crozier Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy J Nutr 138 8 2008 1535S 1542S
19. A. Stalmach, W. Mullen, H. Steiling, G. Williamson, M.E. Lean, and A. Crozier Absorption, metabolism, and excretion of green tea flavan-3-ols in humans with an ileostomy Mol Nutr Food Res 54 3 2010 323 334
20. M.J. Lee, Z.Y. Wang, H. Li, L. Chen, Y. Sun, and S. Gobbo Analysis of plasma and urinary tea polyphenols in human subjects Cancer Epidemiol Biomarkers Prev 4 4 1995 393 399
21. C. Li, X. Meng, B. Winnik, M.J. Lee, H. Lu, and S. Sheng Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry Chem Res Toxicol 14 6 2001 702 707 (Pubitemid 32565720)
22. X. Meng, M.J. Lee, C. Li, S. Sheng, N. Zhu, and S. Sang Formation and identification of 4′-O-methyl-(-)-epigallocatechin in humans Drug Metab Disposition 29 6 2001 789 793
23. J.S. Wang, H. Luo, P. Wang, L. Tang, J. Yu, and T. Huang Validation of green tea polyphenol biomarkers in a phase II human intervention trial Food Chem Toxicol 46 1 2008 232 240 (Pubitemid 350235769)
24. C. Li, M.J. Lee, S. Sheng, X. Meng, S. Prabhu, and B. Winnik Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion Chem Res Toxicol 13 3 2000 177 184 (Pubitemid 30169962)
25. T. Kohri, N. Matsumoto, M. Yamakawa, M. Suzuki, F. Nanjo, and Y. Hara Metabolic fate of (-)-[4-(3)H]epigallocatechin gallate in rats after oral administration J Agric Food Chem 49 8 2001 4102 4112 (Pubitemid 32822744)
26. A. Stalmach, S. Troufflard, M. Serafini, and A. Crozier Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans Mol Nutr Food Res 53 Suppl. 1 2009 S44 53
27. S. Roowi, A. Stalmach, W. Mullen, M.E. Lean, C.A. Edwards, and A. Crozier Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans J Agric Food Chem 58 2 2010 1296 1304
28. K. Nakagawa, and T. Miyazawa Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat J Nutr Sci Vitaminol 43 6 1997 679 684 (Pubitemid 28045726)
29. S. Kim, M.J. Lee, J. Hong, C. Li, T.J. Smith, and G.Y. Yang Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols Nutr Cancer 37 1 2000 41 48 (Pubitemid 30650665)
30. S.M. Henning, W. Aronson, Y. Niu, F. Conde, N.H. Lee, and N.P. Seeram Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption J Nutr 136 7 2006 1839 1843 (Pubitemid 43973585)
31. P. Wang, W.J. Aronson, M. Huang, Y. Zhang, R.P. Lee, and D. Heber Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention Cancer Prev Res (Phila) 3 8 2010 985 993
32. H. Lu, X. Meng, and C.S. Yang Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate Drug Metab Disposition 31 5 2003 572 579 (Pubitemid 36444166)
33. X. Meng, S. Sang, N. Zhu, H. Lu, S. Sheng, and M.J. Lee Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats Chem Res Toxicol 15 8 2002 1042 1050 (Pubitemid 34977270)
34. S. Petti Pooled estimate of world leukoplakia prevalence: a systematic review Oral Oncol 39 8 2003 770 780 (Pubitemid 38373461)
35. C.D. Fuller, S.J. Wang, C.R. Thomas Jr, H.T. Hoffman, R.S. Weber, and D.I. Rosenthal Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998 Cancer 109 7 2007 1331 1343 (Pubitemid 46466560)
36. N. Li, Z. Sun, C. Han, and J. Chen The chemopreventive effects of tea on human oral precancerous mucosa lesions Proc Soc Exp Biol Med 220 4 1999 218 224
37. A.S. Tsao, D. Liu, J. Martin, X.M. Tang, J.J. Lee, and A.K. El-Naggar Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions Cancer Prev Res (Phila) 2 11 2009 931 941
38. H. Kasai Analysis of a form of oxidative DNA damage, 8-hydroxy-2′- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis Mutat Res 387 3 1997 147 163 (Pubitemid 28009270)
39. I.A. Hakim, R.B. Harris, S. Brown, H.H. Chow, S. Wiseman, and S. Agarwal Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study J Nutr 133 10 2003 3303S 3309S (Pubitemid 37222260)
40. I.A. Hakim, R.B. Harris, H.H. Chow, M. Dean, S. Brown, and I.U. Ali Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: role of glutathione S-transferase genotypes Cancer Epidemiol Biomarkers Prev 13 2 2004 242 249 (Pubitemid 38222555)
41. I.A. Hakim, H.H. Chow, and R.B. Harris Green tea consumption is associated with decreased DNA damage among GSTM1-positive smokers regardless of their hOGG1 genotype J Nutr 138 8 2008 1567S 1571S
42. S. Bettuzzi, M. Brausi, F. Rizzi, G. Castagnetti, G. Peracchia, and A. Corti Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study Cancer Res 66 2 2006 1234 1240 (Pubitemid 43165995)
43. J. McLarty, R.L. Bigelow, M. Smith, D. Elmajian, M. Ankem, and J.A. Cardelli Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro Cancer Prev Res (Phila) 2 7 2009 673 682
44. M. Shimizu, Y. Fukutomi, M. Ninomiya, K. Nagura, T. Kato, and H. Araki Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study Cancer Epidemiol Biomarkers Prev 17 11 2008 3020 3025